Listen to my podcast: www.anchor.fm/all4one
For everything else check out my website www.jamielowe.co
could covid 19 trigger diabetes?
like we needed it, but proof that the freestyle libre works
and could a cure be around the corner? a
Emerging evidence suggests that COVID-19 may trigger diabetes in some people – but scientists don’t yet know if these new cases represent type 1 diabetes, type 2, or a new form. Scientists have long suspected viral infections could play a role in triggering type 1 diabetes – at least in some people. Now, the New England Journal of Medicine has published the emerging observations of a team of 17 international researchers exploring links between COVID-19 patients and diabetes. Francesco Rubino, a researcher on the project said: “Diabetes is one of the most prevalent chronic diseases and we are now realizing the consequences of the inevitable clash between two pandemics.
The FreeStyle Libre system significantly improves glycaemic control and hypoglycaemic awareness, according to ABCD’s first national audit into the technology.
The findings were based on data taken from data more than 10,000 FreeStyle Libre system users from across 102 NHS hospitals in the UK. The authors also found the system reduces diabetes distress and hospital admissions, while also improving HbA1c levels. ABCD who carried out the research said so far there has been “no comprehensive, real-world, large population-based data sets looking at the impact of FreeStyle Libre on multiple aspects of diabetes care” The FreeStyle Libre system was made available on the NHS in 2017 to people with type 1 diabetes, who use insulin
An Israeli company claiming to have created a tiny micro-pancreas that can “cure” diabetes for millions of people has said it will submit a request next month for human clinical trials in the UK.
Betalin Therapeutics said its “bio-artificial” pancreas aims to free patients of the need for insulin injections and blood sugar monitoring. It is designed for people with type 1 diabetes, and those with type 2 diabetes who require insulin.
The Jerusalem-based firm told the Guardian it would provide a plan for clinical trials to Britain’s regulatory agency in August. Betalin aims to begin human testing early next year, with the hope of delivering to the market by 2024.
Central to the innovation is a biological scaffold, adapted from pig lung tissue, that holds beta cells. Those cells release insulin based on the patient’s blood sugar levels. The miniature artificial pancreas, just visible to the naked eye, is implanted under the skin on the thigh using local anaesthesia. Trials are planned in several hospitals affiliated with the Leeds and Newcastle universities, with Omar Masood, a UK transplant surgeon with experience in combatting diabetes, directing the project.
Video Rating: / 5